Safety Study of Atomoxetine and Cerebrovascular Outcomes


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- patients 18 years or older
- received dispensing of one of the study medications during the time period of the study (January 1, 2003 - December 31, 2006)
- 6 months of continuous enrollment prior to first dispensing

Exclusion Criteria

- presence of pre-existing arrhythmia and heart failure during the baseline period